BPCR.L vs. V3GU.L

Last updated Apr 2, 2026

Compare and contrast key facts about BioPharma Credit plc (BPCR.L) and Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L).

V3GU.L is a passively managed fund by Vanguard that tracks the performance of the Bloomberg Gbl Agg Corp 0901 TR Hdg USD. It was launched on May 20, 2021.

Performance

BPCR.L vs. V3GU.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioPharma Credit plc (BPCR.L) and Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L). The values are adjusted to include any dividend payments, if applicable.

BPCR.L vs. V3GU.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
BPCR.L BioPharma Credit plc	7.38%	19.78%	22.20%	2.59%	13.30%	3.04%
V3GU.L Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating	-0.53%	6.28%	3.97%	8.61%	-13.25%	-0.93%

Returns By Period

In the year-to-date period, BPCR.L achieves a 7.38% return, which is significantly higher than V3GU.L's -0.53% return.

BPCR.L

• 1D: 0.86%
• 1M: -0.21%
• YTD: 7.38%
• 6M: 7.15%
• 1Y: 22.65%
• 3Y*: 15.34%
• 5Y*: 14.37%
• 10Y*: —

V3GU.L

• 1D: 0.41%
• 1M: -1.38%
• YTD: -0.53%
• 6M: 0.29%
• 1Y: 4.30%
• 3Y*: 5.24%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BPCR.L vs. V3GU.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPCR.L

BPCR.L Risk / Return Rank: 85
BPCR.L Sharpe Ratio Rank: 85
BPCR.L Sortino Ratio Rank: 83
BPCR.L Omega Ratio Rank: 82
BPCR.L Calmar Ratio Rank: 84
BPCR.L Martin Ratio Rank: 90

V3GU.L

V3GU.L Risk / Return Rank: 51
V3GU.L Sharpe Ratio Rank: 49
V3GU.L Sortino Ratio Rank: 46
V3GU.L Omega Ratio Rank: 47
V3GU.L Calmar Ratio Rank: 54
V3GU.L Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPCR.L vs. V3GU.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioPharma Credit plc (BPCR.L) and Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BPCR.L	V3GU.L	Difference
Sharpe ratio Return per unit of total volatility	1.58	0.94	+0.64
Sortino ratio Return per unit of downside risk	2.36	1.33	+1.02
Omega ratio Gain probability vs. loss probability	1.31	1.19	+0.12
Calmar ratio Return relative to maximum drawdown	2.94	1.53	+1.40
Martin ratio Return relative to average drawdown	11.66	6.30	+5.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BPCR.L vs. V3GU.L - Sharpe Ratio Comparison

The current BPCR.L Sharpe Ratio is 1.58, which is higher than the V3GU.L Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of BPCR.L and V3GU.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BPCR.L	V3GU.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.58	0.94	+0.64
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.14	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.95	0.10	+0.85

Correlation

The correlation between BPCR.L and V3GU.L is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BPCR.L vs. V3GU.L - Dividend Comparison

BPCR.L's dividend yield for the trailing twelve months is around 14.18%, while V3GU.L has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BPCR.L BioPharma Credit plc	14.18%	13.78%	14.99%	15.79%	14.30%	10.39%	10.73%	8.96%	10.10%	2.56%
V3GU.L Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

BPCR.L vs. V3GU.L - Drawdown Comparison

The maximum BPCR.L drawdown since its inception was -14.00%, smaller than the maximum V3GU.L drawdown of -18.89%. Use the drawdown chart below to compare losses from any high point for BPCR.L and V3GU.L.

Drawdown Indicators

	BPCR.L	V3GU.L	Difference
Max Drawdown Largest peak-to-trough decline	-14.00%	-18.89%	+4.89%
Max Drawdown (1Y) Largest decline over 1 year	-7.80%	-2.85%	-4.95%
Max Drawdown (5Y) Largest decline over 5 years	-13.92%	—	—
Current Drawdown Current decline from peak	-0.84%	-1.71%	+0.87%
Average Drawdown Average peak-to-trough decline	-2.53%	-7.03%	+4.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.97%	0.70%	+1.27%

Volatility

BPCR.L vs. V3GU.L - Volatility Comparison

BioPharma Credit plc (BPCR.L) has a higher volatility of 4.61% compared to Vanguard ESG Global Corporate Bond UCITS ETF USD Hedged Accumulating (V3GU.L) at 1.89%. This indicates that BPCR.L's price experiences larger fluctuations and is considered to be riskier than V3GU.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BPCR.L	V3GU.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.61%	1.89%	+2.72%
Volatility (6M) Calculated over the trailing 6-month period	9.74%	2.66%	+7.08%
Volatility (1Y) Calculated over the trailing 1-year period	14.25%	4.55%	+9.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	12.58%	6.19%	+6.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	11.89%	6.19%	+5.70%